Health and Science News Roundup
Monsters and Critics.com - Glasgow,UK
The Ohio State University laboratory and animal study focused on a drug, called fingolimod, which is also being tested to prevent organ transplantation ...
See all stories on this topic

Carl Icahn: Biogen Marriage Broker?
xconomy - USA
The share price fell off a cliff in February of 2005--after Biogen's MS drug, Tysabri, was pulled from the US market in light of safety concerns--tumbling ...
See all stories on this topic

Elan, Biogen Idec say Tysabri recommended by NICE for MS treatment
CNNMoney.com - USA
About 14000 patients worldwide receive Tysabri as treatment for multiple sclerosis, Elan said. NICE guidance is crucial for pharmaceutical and biotech ...
See all stories on this topic